Introduction
Understanding the biology and physiology of ion transport has long been an important dominion of nephrologists. Recently, important new insights into the structure and function of ion channels and ion transporters have emerged unexpectedly from work in human genetics. A growing number of hereditary syndromes have been identified that are caused by genetic mutations in genes encoding ion channels (Table 1) . Several inherited renal syndromes have recently been added to this list and include diseases involving sodium, chloride, and water channels. Some of the earliest ion channel diseases to be identified involve non-epithelial tissues such as skeletal muscle, and important lessons can be learned from re-visiting work in these areas. This review will summarize recent discoveries that have served to characterize the molecular and biophysical defects in voltage-gated sodium channels that underlie various inherited disorders of skeletal and cardiac muscle excitability. (Similar work characterizing disorders of renal sodium channels will be the subject of a future review paper in this journal.) It is hoped that this topic will illustrate the application of the genetic paradigm to disorders of ion transport, and the ability of modern biomedical research to define disease pathogenesis at a molecular level.
Structure and function of voltage-gated Na

+ channels
Sodium channels expressed in nerve, heart, and muscle belong to a superfamily of ion channels that are gated (opened and closed) by changes in membrane potential. According to a model developed by Hodgkin and Huxley [1] , changes in the ionic permeability of excitable membranes are controlled by two kinetic processes: activation and inactivation. For example, in skeletal muscle, a sudden membrane depolarization causes a rapid rise in local Na + permeability due to the opening (activation) of voltage-gated Na + channels. This rise in Na + permeability is transient owing to the second process, inactivation. Repolarization of the membrane potential is required for Na + channels to re-enter the closed state and be available again to initiate the next action potential. This is accomplished by the opening of voltage-gated potassium channels that allow potassium ions to flow out of the cell and drive the membrane potential toward more hyperpolarized voltages. The intrinsic property of the muscle membrane to initiate and conduct action potentials in response to synaptic input at the neuromuscular junction is termed excitation [2] . Sodium channel proteins from mammalian brain, muscle, and myocardium have been well characterized and are known to consist of a large (M r~2 60 kDa) pore forming a-subunit and one or two smaller ft subunits [3] . Multiple distinct Na + channel a subunit isoforms have been demonstrated by isolation and sequencing of complementary DNA (cDNA). Unique isoforms exist in skeletal muscle, brain, heart, glia, and certain neuroendocrine tissues that are encoded by separate genes [4] [5] [6] [7] [8] [9] . Deduced amino acid sequences reveal a highly conserved structure consisting of four homologous domains (D1-D4) each containing six membrane spanning segments (S1-S6) (Fig. 1 ).
Skeletal muscle Na + channel diseases
Disturbances in the function of any of the components required for action potential generation or repolarization can affect the ability of skeletal muscle to contract or to relax. Two principle symptoms may arise from abnormal sarcolemmal excitability: myotonia and periodic paralysis. Myotonia is characterized by delayed relaxation of muscle following a sudden forceful voluntary contraction and is associated with repetitive generation of muscle action potentials (hyperexcitability). Myotonia is most often described by patients as painless muscle stiffness. In contrast, periodic paralysis represents a transient state of hypoexcitability or inexcitability in which muscle action potentials cannot be generated or propagated. Periodic paralysis is characterized by episodic weakness or paralysis of voluntary muscles occurring in the absence of neuromuscular junction or motor neuron disease [10] . Attacks of weakness are often associated with changes in the serum K + concentration as a result of abrupt redistribution of intracellular and extracellular K + . Periodic paralysis may occur as a familial condition segregating as an autosomal dominant trait, and is typically classified as either hypokalaemic, hyperkalaemic, or normokalaemic. Hyperkalaemia and hypokalaemia in these patients often comes to the attention of nephrologists who should recognize and understand these syndromes in order to initiate appropriate management.
Clinical pheno types
The clinical classification of the non-dystrophic myotonias and periodic paralysis is given in Table 2 . Patients with hyperkalaemic periodic paralysis (HYPP) present typically in childhood with episodic attacks of limb weakness associated with increased serum K + concentration [10] . In many families there is also demonstrable percussion myotonia. In patients with paramyotonia congenita (PC) the dominant clinical picture is cold-induced muscle stiffness and weakness, although some patients may have attacks of weakness or paralysis in the absence of cold [10, 11] . A variety of other syndromes have been described that do not
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• HYPP • PC SCM LQT fit cleanly into either the HYPP or PC classifications. All of these other syndromes have in common the presence of myotonia without weakness [12] . In some cases the myotonia is mild and fluctuating (myotonia fluctuans) [13] , while in other rare cases it can be quite severe, constant, and debilitating (myotonia permanens) [14] . Other syndromes have been recognized based on the aggravation of myotonia with K + ingestion [12] or by the amelioration of muscle stiffness with acetazolamide treatment [15] .
Pathophysiology
Electrophysiological studies have determined that both myotonia and periodic paralysis are associated with abnormal muscle cell membrane ionic conductances [16] . Work by Lehmann-Horn et al. has provided evidence for Na + channel dysfunction in various types of myotonia and periodic paralysis [17] . Taking intercostal muscle fibers from patients with paramyotonia congenita for use in in vitro voltage-clamp recording, these investigators observed spontaneous depolarization of the membrane potential when the fibers were cooled to 27°C. The cooled, depolarized fibers initially exhibited a high level of spontaneous electrical and mechanical activity and then became electrically inexcitable. The spontaneous depolarization could be prevented by tetrodotoxin (TTX), which blocks voltagegated Na + channels. Similarly, muscle fibers excised from patients with hyperkalaemic periodic paralysis exhibit spontaneous depolarizations and concomitant inexcitability upon exposure to elevated extracellular K + concentrations [18] . Membrane depolarization in HYPP fibers can be blocked by TTX, and the spontaneous depolarization seen in these experiments was therefore attributed to abnormal function of muscle voltage-gated Na + channels [19] . Using the patch clamp technique, Cannon et al. identified a subpopulation of Na + channels in cultured HYPP myotubes that exhibited noninactivating behavior in elevated extracellular K + .
Molecular genetics
Based upon the pathophysiological data, several groups of investigators chose to exploit a candidate gene approach to defining the genetic basis for periodic paralysis and myotonia, and directly examine the human skeletal muscle voltage-gated Na 1 " channel a subunit gene (SCN4A) for linkage to these syndromes.
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To examine SCN4A as a candidate gene for hereditary muscle diseases, cDNA probes were isolated [20] [21] [22] and used to determine the location of the gene (chromosome 17q23.1-25.2) [21, 23] , and to define restriction fragment length polymorphisms [21, 24] . Several multi-generation families affected with various forms of periodic paralysis were next examined for linkage to SCN4A or to the neighboring growth hormone (GH) gene cluster. This work demonstrated tight linkage of the SCN4A/GH complex to the phenotypes HYPP [21, 25] and PC [26, 27] , but not to hypokalaemic periodic paralysis [28] . These data provided further support for the hypothesis that the skeletal muscle Na + channel gene was involved in the pathogenesis of some forms of periodic paralysis and myotonia, and that HYPP and PC were likely to be allelic disorders of the same gene. By contrast, hypokalemic periodic paralysis has been subsequently shown to be linked to a gene encoding a subunit of the skeletal muscle Ca 2+ channel [29] [30] [31] .
After establishment of genetic linkage between the SCN4A/GH complex on 17q and the HYPP/PC phenotypes, a direct search for specific disease-associated mutations in the Na + channel coding sequence was undertaken. This involved either direct sequencing of cDNA derived from affected muscle tissue, or application of single strand conformational analysis [32] to screen for single nucleotide differences between normal and disease patient DNAs. To facilitate the search for mutations without requiring muscle tissue, the complete genomic organization of SCN4A was defined [33, 34] , and exon specific PCR primers were developed. Several distinct point mutations resulting in nonconservative amino acid substitutions were rapidly discovered using these methods, and to date there have been 19 reported SCN4A mutations [12, [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] (Fig. 1) . In general, there are distinct mutations associated with specific clinical syndromes (genotypephenotype correlation), although the distribution of mutations throughout the Na + channel sequence does not reveal any close correlation between structure and phenotype ( Fig. 1) . Hyperkalemic and normokalemic periodic paralysis are associated with the same subset of SCN4A alleles, while paramyotonia congenita is caused by distinct mutations. Additional families segregating other forms of non-dystrophic myotonia without weakness that do not fit well with either HYPP or PC have also been shown to have SCN4A mutations; the term 'sodium channel myotonia' was coined to encompass this group of clinical entities [12, 45] .
Functional characterization of mutant Na + channels
The final proof that a given mutation in the Na + channel gene is functionally significant has been provided by in vitro expression of recombinant channels modified by site-directed mutagenesis. Several SCN4A mutations have so far been functionally characterized and the corresponding biophysical abnormalities correlated with the respective phenotype. In general, SCN4A mutations found in HYPP, PC, and sodium Na + channel diseases 1733 channel myotonia affect Na + channel function in distinct ways.
Two HYPP mutations, T704M and Ml592V, have been constructed in the rat homolog of SCN4A, expressed transiently in mammalian cells, and examined by whole-cell or single channel electrophysiologic recording methods [46, 47] . In both studies, the expressed mutant channel exhibited a small persistent Na + current occurring late in test depolarizations, but had normal rates of activation and inactivation. Similar observations were made using recombinant human SCN4A to express the T704M mutation (Fig. 2) [48] . In the expressed human T704M, the persistent late current was explained by a combination of a hyperpolarizing shift of steady-state activation with a depolarizing shift of steady-state inactivation. These shifts create a range of voltages (-65 to -30 mV) over which a steady-state Na + current will flow (ie: persistent Na + current at voltages where the activation and inactivation curves overlap; Fig. 2D ). The occurrence of this persistent current will tend to cause depolarization of skeletal muscle cells in HYPP patients, and lead to inexcitability. In contrast, Na + channel mutations found in PC exhibit normal activation kinetics, but have in common disturbances in inactivation: inactivation rate is slowed, but recovery from inactivation is accelerated ( Fig. 2A,B) [48] . In this situation, mutant Na + channels will have prolonged open times, permit persistent Na + influx, and therefore maintain the membrane in a depolarized state. Mutations associated with various 'sodium channel myotonias' exhibit heterogenous functional defects. One mutation, V1589M associated with potassium-aggravated myotonia causes a persistent late current in combination with faster recovery from inactivation [49] . This mutant has normal activation and inactivation rates. Three additional mutations all occurring at codon 1306 and result in replacement of the wild-type glycine residue with either alanine (G1306A), valine (G1306V), or glutamic acid (G1306E) all exhibit slowed inactivation rate but had normal recovery from inactivation [50] . In addition, the G1306E mutation which is associated with a severe permanent myotonia (myotonia permanens) has additional disturbances in activation. These unique biophysical fingerprints provide a molecular correlate of the varied clinical phenotypes (Table 3 ).
Molecular mechanisms
It has been suggested that the degree of membrane depolarization associated with abnormal Na + channel function may determine whether myotonia or weakness predominates [19, 51] . Small depolarizations might cause hyperexcitability while larger depolarizations would sufficiently inactivate normal Na + channels to cause inexcitability. More rapid recovery from inactivation should also facilitate regeneration of the excitable state after propagation of an action potential and contribute to the development of myotonia. It is also important to consider the roles of extracellular potassium concentration and the transverse tubules (t-tubules) in contributing to these disturbances in muscle excitation [52] . The t-tubules are invaginations of the surface membrane that are critical for rapid spread of excitation into the fiber core. During action potential propagation, extracellular potassium concentration in the t-tubules rises sharply causing afterdepolarizations (spontaneous membrane depolarization following an action potential). The role of the t-system and the importance of potassium accumulation has been demonstrated using a theoretical model which reconstructs the muscle action potential under normal and situations of Na + channel dysfunction [52] . These findings clearly show that slowing of inactivation and persistent late Na + currents favor generation of repetitive action potentials (myotonia) and depolarization block of excitation (paralysis), respectively.
Long QT syndrome, a cardiac ion channel disease
Cardiac arrhythmias are believed to be responsible for most cases of sudden death in adults. An important and identifiable risk factor for developing lifethreatening ventricular arrhythmias is prolongation of the QT interval [53, 54] . Lengthening of the QT interval is the hallmark of delayed myocardial repolarization and prolongation of the cardiac action potential, phenomena that can increase the susceptibility to triggered arrhythmias. Molecular genetics has recently made substantial advances in our understanding of arrhythmogenesis by unveiling the cause of an hereditary syndrome known to predispose young adults and children to syncope and sudden death from cardiac arrhythmias, the congenital long QT syndrome (CLQTS) [55, 56] .
Clinical phototypes
CLQTS is a rare familial disorder in which abnormalities in cardiac repolarization, reflected as a lengthening of the QT interval on surface electrocardiographs of affected individuals, increase the susceptibility to development of triggered arrhythmias [56] . Patients with this syndrome may develop an unusual form of polymorphic ventricular tachycardia (torsade de pointes) in response to acute adrenergic stimulation accompanying sudden emotional reactions or physical stress.
Two forms of CLQTS can be distinguished based upon their inheritance pattern and the presence of extra-cardiac manifestations. In 1957, Jervell and Lange-Nielsen described a syndrome of prolonged QT interval, congenital neural deafness, and an increased incidence of sudden death [57] . This syndrome is transmitted by autosomal recessive inheritance and is extremely rare. A few years after description of Jervell-Lange-Nielsen syndrome, Romano and Ward independently reported an autosomal dominant disorder featuring long QT, normal hearing, and a high incidence of syncope and sudden death in affected families [58, 59] . The Romano-Ward syndrome is also rare, although an international registry of patients has identified several hundred cases [60] .
Pathophysiology
Before 1995, two competing theories existed to explain CLQTS. One theory favored an imbalance in sympathetic innervation of the heart, while another hypothesized an intrinsic defect in repolarizing ionic currents [55] . Unlike the skeletal muscle Na + channel diseases, no direct in vitro experimental data was available on CLQTS myocardium to guide selection of candidate genes, and therefore the identification of CLQTS genes required a systematic survey of the entire genome. Na" 1 channel diseases
Molecular genetics
Beginning in 1991, Keating and colleagues began a search for genetic loci that cause CLQTS using linkage analysis as a tool. Initially, work with a single large Utah kindred led to the identification of the LQTl locus on chromosome 1 Ipl5.5 [61] . This was soon followed by both confirming reports in other families [62] and evidence for other genetic loci in phenotypically similar CLQTS families [63] . In late 1994, discoveries of two additional loci (LQT2, 7q35-36; LQT3, 3p21-24) were reported [64] . Soon after the report by Jiang et al. [64] describing linkage of 3p markers to a small number of families with CLQTS, George et al. reported the localization of SCN5A, the gene encoding the cardiac voltagegated Na + channel a subunit, to 3p21 [65] . The coinciding localization of SCN5A with the LQT3 locus established this gene as a candidate for CLQTS. The candidacy of SCN5A as a CLQTS gene could also be supported by previous electrophysiological studies demonstrating the arrhythmogenic potential of disrupting cardiac Na + channel inactivation with neurotoxins [66] .
Using single strand conformation analysis, Wang et al. examined patient DNAs for abnormalities in regions of SCN5A known to be involved in inactivation [67] . In two of three CLQTS families linked to 3p21-24, an in-frame 9 nucleotide deletion was detected that causes absence of a tripeptide sequence of lysine, proline, and glutamine (AKPQ) within a cytoplasmic linker region located between domains 3 and 4 ( Fig. 1) . Subsequently, two additional missense mutations in SCN5A were discovered in additional LQT3 families [68] . Two other ion channel genes have been found responsible for LQTl and LQT2 forms of the disease, and both encode potassium channels that likely are important in repolarization [69, 70] ,
Characterization of mutant cardiac Na + channels
For a more complete understanding of the molecular pathophysiology of this form of CLQTS, Bennett and colleagues constructed a AKPQ mutant recombinant human cardiac Na + channel for use in expression studies in Xenopus oocytes [71] . Using both twoelectrode voltage-clamp and patch clamp recording techniques, comparisons were made between wild-type and mutant Na + channels. These investigations demonstrated a small but significant persistent Na + current occurring late in depolarizations in the mutant but not wild-type Na + channels. The magnitude of this late current was between 3-5% of the maximal currents conducted by the channels. At the level of single channels, the AKPQ mutant exhibits episodic noninactivating behavior that fully accounts for the late current observed in the two-electrode recordings (Fig. 3) . These findings were explained by an increased tendency of mutant channels to enter a noninactivating state. 
Molecular mechanisms
Persistence of Na + current during a cardiac action potential can fully explain the defect in repolarization in CLQTS. Action potentials in heart last several hundred milliseconds mainly due to a prolonged depolarization phase called the plateau. The plateau phase is the result of opposing inward (Na + , Ca 2+ ) and outward (K + ) ionic currents that maintain the membrane in a depolarized state. Repolarization occurs when the outward currents, largely carried by K + exceed the inactivating inward currents. A sustained current as carried by mutant Na + channels will shift this balance toward the inward currents and delay onset of repolarization. This will be manifest as lengthening of the Q-T interval and increase the susceptibility toward potentially lethal cardiac arrhythmias.
Summary
Genetic disorders of ion channel function are being increasingly recognized due to advances in molecular genetic techniques. Disorders such as those illustrated herein, offer unique opportunities to correlate clinical phenotypes to specific physiological disturbances at the molecular level. These advances in understanding pathophysiology will almost certainly lead to more rationale drug therapy, improved diagnosis, and a more complete appreciation for the importance of ion channels in health and disease.
